Dr. Lawson most recently served as president and CEO of Humacyte, a regenerative medicine company, according to a March 8 news release from VarmX. He previously served as director of clinical trials for the department of surgery at Duke University Medical Center in Durham, N.C.
Dr. Lawson is succeeding Pieter Reitsma, PhD, founder of VarmX, who will serve as special adviser to the company’s board, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
